[1] 梅瑞平,熊江琴,周槐娜,等. 肝源性糖尿病的临床研究.实用肝脏病杂志,2011,14(1):56-58. [2] 胡庆玲,黄亚雄,谢元林,等.肝源性糖尿病发病机制研究进展.实用肝脏病杂志,2016,19(3):377-380. [3] Holstein A,Hinzeet S.Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol,2002,17(6):677-618. [4] Emanuela O,Valeria G.Hepatogenous diabetes:Is it time to sepa-rate it from type 2 diabetes Liver Int,2017,37(7):950-962. [5] Hyo M,Young K.Hepatogenous diabetes in cirrhosis is related to portal pressure and variceal hemorrhage. Dig Dis Sci,2013,58(11):3335-3341. [6] Gundling F,Seidl H.Metabolic disturbances in liver cirrhosis (part2),hepatogenous diabetes. Dtsch Med Wochenschr,2010,135(1):22-24. [7] Hatanaka SA,Silva NO,Colombo BS,et al.Factors associated with elevated serum alanine aminotransferase in patients with type 1 diabetes mellitus. Minerva Gastroenterol Dietologica,2015,61(3):137-143. [8] Holstein A,Hinze S.Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol,2002,17(6):677-681. [9] Gundling F,Schumm-Draeger P.Hepatogenous diabetes-diagnostics and treatment. Z Gastr,2009,47(5):436-445. [10] 钱春荣,朱京慈,黄志玉,等. 以小群体为基础的脑卒中健康教育课程的建立和效果评价. 中华护理杂志,2010,45(12):1069-1072. [11] Laure E,Pierre-Emmanuel R.Diabetes mellitus in patients with cirrhosis:clinical implications and management. Liver Int,2016,36(7):936-948. [12] García D,JaquezO. Hepatogenous diabetes. Current views of an ancient problem. Ann Hepatol,2009,8(1):13-20. [13] Kalantzi S,Kostagiolas P,Kechagias G,et al.Information seeking behavior of patients with diabetes mellitus:a cross-sectional study in an outpatient clinic of a university-affiliated hospital in Athens,Greece. BMC Res Not,2015,8(1):1005. [14] Sukumaran S,Muthukumaran K.A study of hepatogenous diabetes in patients with chronic liver disease. J Clin Exp Hepatol,2015,5(2):S38. [15] 邱春婷,王怡,周莉,等. 血清谷氨酸脱羧酶抗体在诊断肝源性糖尿病中的价值. 广东医学,2013,34(13):2066-2068. |